HomeTGTX • NASDAQ
add
TG Therapeutics Inc common stock
Previous close
$17.96
Day range
$17.63 - $18.41
Year range
$6.46 - $31.81
Market cap
2.74B USD
Avg Volume
3.83M
P/E ratio
80.37
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 63.47M | 713.46% |
Operating expense | 67.30M | 53.18% |
Net income | -10.71M | 72.71% |
Net profit margin | -16.87 | 96.64% |
Earnings per share | -0.07 | 75.00% |
EBITDA | -9.24M | 74.97% |
Effective tax rate | -0.27% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 209.78M | 50.16% |
Total assets | 373.32M | 89.16% |
Total liabilities | 213.21M | 25.48% |
Total equity | 160.11M | — |
Shares outstanding | 143.14M | — |
Price to book | 16.04 | — |
Return on assets | -6.59% | — |
Return on capital | -8.52% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.71M | 72.71% |
Cash from operations | -8.21M | 86.30% |
Cash from investing | -9.26M | -50.05% |
Cash from financing | 10.00K | -99.96% |
Net change in cash | -17.45M | 57.26% |
Free cash flow | -1.46M | 96.83% |
About
Founded
1993
Headquarters
Website
Employees
284